Lipid composition of myelin in multiple sclerosis

Journal of Neurology
|August 6, 1976
PubMed

Insights

Multiple sclerosis (MS) myelin shows no lipid composition differences compared to normal myelin. This study found no deficits in key myelin lipids, suggesting myelin lipid structure is preserved in MS plaques.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Multiple Sclerosis (MS) is a demyelinating disease affecting the central nervous system.
  • Understanding myelin composition in MS is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the lipid composition of myelin in MS plaques.
  • To compare MS myelin with myelin from normal controls.

Main Methods:

  • Myelin was isolated from normal white matter, MS plaques, and control white matter.
  • Total lipid content was analyzed.
  • Specific lipid classes (phosphoglycerides, plasmalogens, sphingolipids) were quantified.
  • Fatty aldehyde and fatty acid compositions were analyzed.

Main Results:

  • No significant differences were observed in total lipid content between normal and MS myelin.
  • No detectable deficits in phosphoglycerides, plasmalogens, or sphingolipids were found in MS myelin.
  • Fatty aldehyde and fatty acid compositions of various lipid classes were similar in normal and MS myelin.

Conclusions:

  • Myelin lipid composition appears to be largely preserved in MS plaques.
  • The study did not identify lipid deficits as a primary feature of MS myelin alteration.

Related Concept Videos

Membrane Lipids01:32

Membrane Lipids

Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...